Overview
Spontaneous coronary artery dissection (SCAD) is an increasingly recognised cause of non-atherosclerotic acute coronary syndromes (ACS), predominantly afflicting young women without conventional atherosclerotic risk factors. Knowledge of SCAD has advanced considerably in the last few years as a result of data from a number of local and national registries 1-6. Like all rarer diseases however, a better understanding of SCAD will require international collaboration. At present, there is no European or International SCAD registry despite increasing recognition that there are key differences in the diagnosis, interventional and medical management of SCAD compared with conventional atherosclerotic ACS. The ESC-ACCA Study Group on Spontaneous Coronary Artery Dissection supported by the European Observational Research Programme will now build the first pan-European SCAD registry to advance our understanding of current management of this condition, inform guidelines, educate clinical colleagues and advance research.
Description
Observational, multicentre, international retrospective and prospective cohort study.
Since this is an observational study, a formal sample size is not necessary. At least 500 prospectively recruited patients and 500 historical cases will be enrolled.
Patient data will be collected at the following time-points:
- First SCAD event visit (retrospectively on chart review)
- First follow-up: at time of enrolment
- Yearly follow-up: up to 1, 2, 3, 4 and 5 years post enrolment or until study completion
Approximately 30 countries and 120 sites will participate in this registry.
Eligibility
Inclusion Criteria:
- Patient having signed an Informed Consent
- Patient aged 18 years and over
- SCAD clinical diagnosis within the past 10 years and available coronary angiographic imagery
Exclusion Criteria:
- Patient unwilling or unable to consent
- Patients with iatrogenic or atherosclerotic coronary dissection